The aim of the study was the assessment of FGF21 concentrations in the serum of 2DM patients as well as GDM women, in comparison to controls and an attempt to evaluate the possible relationship between the studied protein and selected biochemical parameters. This evidence concerns the gene FGF21 and gestational diabetes.